Side-effect management of chimeric antigen receptor (CAR) T-cell therapy

Схожие документы

• Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)
  по: Hofmann, Susanne, и др.
  Опубликовано: (2019)
• Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)
  по: Susanne Hofmann, и др.
  Опубликовано: (2019)
• Chimeric antigen receptor transduced T cells: Tuning up for the next generation
  по: Maria‐Luisa Schubert, и др.
  Опубликовано: (2017)
• Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma
  по: Korell, Felix, и др.
  Опубликовано: (2021)
• Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19-positive malignancies
  по: Wang, Sanmei, и др.
  Опубликовано: (2021)